RBC Capital Raises its Price Target on Neurocrine Biosciences (NBIX)

On May 29, 2026, RBC Capital raised the firm’s terms people connected Neurocrine Biosciences, Inc. (NASDAQ:NBIX) to $183 from $180 and maintained an Outperform standing connected the shares. RBC said the banal has rebounded aft a beardown Q1, though concerns stay that Crenessity uptake could deed a near-term ceiling. RBC besides said its endocrinologist survey suggests country for near- and semipermanent growth, including expected utilization maturation among doctors not presently utilizing the drug.

On May 21, 2026, Bernstein expert Jeffrey Walch initiated sum of Neurocrine Biosciences, Inc. (NASDAQ:NBIX) with an Outperform standing and a $221 terms target. Walch described Neurocrine arsenic 1 of the much promising names successful Bernstein’s archetypal sum radical of mid-cap biopharmaceutical companies, noting that the company’s 2 cardinal medicines are already approved and person a agelong runway until loss-of-exclusivity. Bernstein added that upside could travel arsenic the marketplace gains much certainty astir aboriginal marketplace stock and a Phase 3 proceedings readout.

create jobs 51/Shutterstock.com

Earlier successful May, Neurocrine Biosciences, Inc. (NASDAQ:NBIX) reported Q1 adjusted EPS of $1.94, up of the statement estimation of $1.70. Revenue totaled $811M, supra the statement estimation of $767.88M. CEO Kyle Gano said the 4th reflected “continued momentum” crossed the commercialized portfolio, with nett merchandise income up 44% year-over-year, driven by request for INGREZZA and CRENESSITY. Gano besides cited the statement to get Soleno Therapeutics and the company’s pipeline.

Neurocrine Biosciences, Inc. (NASDAQ:NBIX) discovers, develops, and commercializes pharmaceuticals for neurological, psychiatric, endocrine, and immunological disorders successful the United States and internationally.

While we admit the imaginable of NBIX arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 33 Stocks That Should Double successful 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy. 

Disclosure: None. Follow Insider Monkey connected Google News.